Cipla submits application with USFDA for generic version of asthma drug

Drug major Cipla on Monday said it has submitted an application with the US health regulator for a generic version of GSK's Advair Diskus, which is used in the treatment of asthma and other respiratory disorders.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2zKAIl1
via IFTTT